236 related articles for article (PubMed ID: 10935943)
1. Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study.
Vandersmissen G; Moens G; Vranckx R; de Schryver A; Jacques P
Occup Environ Med; 2000 Sep; 57(9):621-6. PubMed ID: 10935943
[TBL] [Abstract][Full Text] [Related]
2. Nosocomial transmission of chickenpox and varicella zoster virus seroprevalence rate amongst healthcare workers in a teaching hospital in China.
Yang J; Liu J; Xing F; Ye H; Dai G; Liu M; Lo SK; Lau RW; Chiu KH; Chan JF; Yuen KY
BMC Infect Dis; 2019 Jul; 19(1):582. PubMed ID: 31277589
[TBL] [Abstract][Full Text] [Related]
3. Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection.
Wu MF; Yang YW; Lin WY; Chang CY; Soon MS; Liu CE
J Hosp Infect; 2012 Feb; 80(2):162-7. PubMed ID: 22188630
[TBL] [Abstract][Full Text] [Related]
4. Varicella zoster virus in health care workers in northern Israel: seroprevalence and predictive value of history of varicella infection.
Chazan B; Colodner R; Teitler N; Chen Y; Raz R
Am J Infect Control; 2008 Aug; 36(6):436-8. PubMed ID: 18675150
[TBL] [Abstract][Full Text] [Related]
5. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
[TBL] [Abstract][Full Text] [Related]
6. Varicella-zoster virus immunity among health care workers in Catalonia.
Urbiztondo L; Bayas JM; Broner S; Costa J; Esteve M; Campins M; Borrás E; Domínguez A;
Vaccine; 2014 Oct; 32(45):5945-8. PubMed ID: 25219564
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of antibodies against varicella zoster virus and rubella virus among newly recruited expatriate healthcare workers: a cross-sectional study.
Shady I
BMJ Open; 2018 Mar; 8(3):e019339. PubMed ID: 29567844
[TBL] [Abstract][Full Text] [Related]
8. Varicella-zoster virus seroprevalence in healthcare workers in Kuala Lumpur, Malaysia.
Sam IC; Tariman H; Chan YF; Bador MK; Yusof MY; Hassan H
Med J Malaysia; 2008 Dec; 63(5):429-30. PubMed ID: 19803311
[TBL] [Abstract][Full Text] [Related]
9. Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study.
Bianchi FP; Tafuri S; Larocca AMV; Germinario CA; Stefanizzi P
BMC Infect Dis; 2021 May; 21(1):475. PubMed ID: 34034659
[TBL] [Abstract][Full Text] [Related]
10. Seroepidemiology of Varicella and value of self-reported history of Varicella infection in Iranian medical students.
Allami A; Mohammadi N; Najar A
Int J Occup Med Environ Health; 2014 Apr; 27(2):304-13. PubMed ID: 24715422
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to varicella-zoster virus in applicants for nurse training in Scotland.
Waclawski ER; Stewart M
Commun Dis Public Health; 2002 Sep; 5(3):240-2. PubMed ID: 12434695
[TBL] [Abstract][Full Text] [Related]
12. Screening healthcare workers for varicella-zoster virus: can we trust the history?
Almuneef M; Memish ZA; Abbas ME; Balkhy HH
Infect Control Hosp Epidemiol; 2004 Jul; 25(7):595-8. PubMed ID: 15301033
[TBL] [Abstract][Full Text] [Related]
13. Outbreak of varicella-zoster virus infection among Thai healthcare workers.
Apisarnthanarak A; Kitphati R; Tawatsupha P; Thongphubeth K; Apisarnthanarak P; Mundy LM
Infect Control Hosp Epidemiol; 2007 Apr; 28(4):430-4. PubMed ID: 17385149
[TBL] [Abstract][Full Text] [Related]
14. Varicella-zoster virus immunity in dermatological patients on systemic immunosuppressant treatment.
Hackett CB; Wall D; Fitzgerald SF; Rogers S; Kirby B
Br J Dermatol; 2011 Jun; 164(6):1387-9. PubMed ID: 21410679
[TBL] [Abstract][Full Text] [Related]
15. The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium).
Thiry N; Beutels P; Shkedy Z; Vranckx R; Vandermeulen C; Wielen MV; Damme PV
Eur J Pediatr; 2002 Nov; 161(11):588-93. PubMed ID: 12424583
[TBL] [Abstract][Full Text] [Related]
16. Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines.
Kopylov U; Levin A; Mendelson E; Dovrat S; Book M; Eliakim R; Ben-Horin S
Aliment Pharmacol Ther; 2012 Jul; 36(2):145-50. PubMed ID: 22612376
[TBL] [Abstract][Full Text] [Related]
17. Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults.
Koturoglu G; Kurugol Z; Turkoglu E
Paediatr Perinat Epidemiol; 2011 Jul; 25(4):388-93. PubMed ID: 21649681
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Characteristics of Pediatric Healthcare Workers without Immunity to Varicella zoster Virus.
Anugulruengkitt S; Puthanakit T; Siengboon S; Paitoonpong L; Kowitdamrong E; Pancharoen C; Pichitchok Y
Jpn J Infect Dis; 2017 Mar; 70(2):216-218. PubMed ID: 27580582
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities in Xingu National Park, Brazil, before varicella vaccination.
Lafer MM; de Moraes-Pinto MI; Weckx LY
Rev Inst Med Trop Sao Paulo; 2005; 47(3):139-42. PubMed ID: 16021286
[TBL] [Abstract][Full Text] [Related]
20. A seroepidemiologic survey of the prevalence of varicella-zoster virus in the pediatric population in two university hospitals in Brazil.
Semenovitch I; Lupi O
Int J Dermatol; 2003 Mar; 42(3):193-6. PubMed ID: 12653913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
